Moreover, the expression level of SIRT3 can also be reduced by some compounds, thereby demonstrating the same effect as SIRT3 inhibitors, ultimately exerting antitumor activity and potentially offering therapeutic benefits for cancer treatment. The gene discussed is SIRT3; the disease is cancer.